Consolidated Balance Sheet (Parenthetical) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2025	Dec. 31, 2024
Restricted cash		$ 47,671	$ 43,371
Deferred financing costs		$ 37,041	$ 28,306
Common shares, par value		$ 0.001	$ 0.001
Common Stock, Shares Authorized, Unlimited [Fixed List]		Unlimited	Unlimited
Common shares, issued		146,285,685	140,208,028
Common shares, outstanding	[1]	146,285,685	140,208,028
Non-controlled, Non-affiliated Investments
Investments at amortized cost		$ 7,892,866	$ 7,079,994

[1] Table may not sum due to rounding.